MONTREAL, March 19, 2026 /PRNewswire/ -- Congruence Therapeutics today announced that the first participant has been dosed in its Phase 1/1b clinical trial evaluating CGX-926, an oral small-molecule ...

The Relist Watch column examines cert petitions that the Supreme Court has “relisted” for its upcoming conference. A short explanation of relists is available here. There are 261 petitions and ...

Despite warnings from early childhood experts against too much screen time, schools' reliance on educational technology for grade levels as low as transitional kindergarten has grown — and frustrated ...

Vulnerabilities found in low-cost KVM devices can give attackers the equivalent of physical access to everything they connect to.

Rather than an honorific like Mr. or Mrs., one Clarksville teacher goes by “Teacher B.” However, a bill is working its way ...

The Iger era has come to an end at the Walt Disney Company.

Don't let fear or frustration force you to give up something you love. It may be a process of adaptation and discovery, but ...

Researchers at the National University of Singapore have engineered a common gut bacterium to carry a chemotherapy prodrug ...

Most of us spent years worrying about plagiarism, citation errors, and the occasional ghostwriter. Suddenly, in what felt like an instant, generative AI ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...